Source: Annual Congress 2002 - Pathophysiology of interstitial and vascular lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Bühling, A. Gerber, C. Röcken, T. Welte (Magdeburg, Germany). Is cathepsin K a protective factor in the development of lung fibrosis?. Eur Respir J 2002; 20: Suppl. 38, 3016

Member's Comments

No comment yet.

Related content which might interest you: A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Potential role of cathepsin S in bleomycin-induced lung fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 The role of cathepsin S in lung disease Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Targeting of cathepsin S reduces cystic fibrosis-like lung disease Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018 Year: 2019 Cathepsin S as a mediator of acute lung inflammation Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Evidence that cathepsin G counteracts the profibrotic effects of neutrophil elastase following lung injury Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Cathepsins in bleomycin-induced lung injury in rat Source: Eur Respir J 2003; 22: 427-435 Year: 2003 Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 The role of cathepsin S in the development of inflammation in patients with severe bronchial asthma Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Growth factor regulation of lung fibrosis lessons from other organs Source: Annual Congress 2006 - Scientific year in review Year: 2006 Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Source: Eur Respir J 2004; 23: 620-628 Year: 2004 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Increased alveolar soluble annexin V promotes lung inflammation and fibrosis Source: Eur Respir J 2015; 46: 1417-1429 Year: 2015 Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001 Correlation between tenascin C and tissue factor in patients with interstitial lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012